Impact of mobile technologies on cervical cancer screening practices in Lagos, Nigeria (mHealth-Cervix): Protocol for a randomised controlled trial

Okunade, Kehinde Sharafadeen; Salako, Omolola; Adejimi, Adebola A; Akinsola, O J; Fatiregun, Omolara; Adenekan, Muisi A; Moses, Olusanjo E; Ebenso, Bassey; Allsop, Matthew J; Anorlu, Rose; Berek, Jonathan S.

doi:10.12688/f1000research.22991.1

Cited by 14 publications

(16 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The trial Protocol was registered on the Pan African Clinical Trial Registry ( PACTR202002753354517 ). The detailed Protocol is published elsewhere 9 and some of the details are described below.…”

Section: Methodsmentioning

confidence: 99%

“…The allocation sequence was kept in sealed opaque envelopes that were stored in locked file cabinets at the study sites until participants' assignments were completed. mHealth arm —We modified the study Protocol 9 by choosing MultiTexter Bulk SMS as the platform to deliver the mHealth text messages. Participants were sent messages containing health promotion information on cervical cancer screening twice monthly for 6 months after enrollment.…”

Section: Methodsmentioning

confidence: 99%

“…mHealth arm —We modified the study Protocol 9 by choosing MultiTexter Bulk SMS as the platform to deliver the mHealth text messages. Participants were sent messages containing health promotion information on cervical cancer screening twice monthly for 6 months after enrollment.…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Impact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial

Okunade

Soibi‐Harry

John‐Olabode

et al. 2021

JCO Global Oncology

Self Cite

View full text Add to dashboard Cite

PURPOSE We assessed the impact of mHealth on Pap test screening uptake and also determined the factors that affect screening uptake among women in Lagos, Nigeria. MATERIALS AND METHODS A randomized controlled trial was carried out among women in two tertiary health institutions in Lagos, Nigeria, between July 2020 and March 2021. Participants were randomly assigned to either a text message (mHealth) intervention or usual care arm. The main study outcome was the uptake of Pap smear testing within 6 months of enrollment in the study. We tested the associations between two groups of continuous variables using the unpooled independent-sample t-test (normal distribution) and that of two groups of categorical variables with the chi-square (χ2) test. Using a multinomial logistic regression model, we adjusted for relevant sociodemographic and clinical predictors of uptake of Pap smear screening. Statistical significance was defined as P < .05. RESULTS There was a significantly higher rate of uptake of Pap smear screening among women in the mHealth arm compared with those in the usual care arm (51.0% v 35.7%, P = .031). Following adjustment in the final multivariate model, level of income (odds ratio [OR] = 5.13, 95% CI, 1.55 to 16.95), awareness of Pap smear (OR = 16.26; 95% CI, 2.49 to 76.64), General Outpatient clinic attendance, and introduction of mHealth intervention during follow-up (OR = 4.36; 95% CI, 1.44 to 13.22) were the independent predictors of Pap smear uptake. CONCLUSION The use of mHealth technologies intervention via short-text message services is a feasible solution for cervical cancer prevention in low- and middle-income countries, and thus, the widespread use of mHealth services by health care providers and policymakers could contribute to the implementation of cervical cancer prevention services in Nigeria and in the settings of other low- and middle-income countries.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Impact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial

Okunade

Soibi‐Harry

John‐Olabode

et al. 2021

JCO Global Oncology

Self Cite

View full text Add to dashboard Cite

show abstract

“…Among women receiving treatment for BC, Jongerius and colleagues (2019) found that mHealth interventions were effective in promoting weight loss, decreasing stress and improving the quality of life [30]. Another study [33] also predicted that after the COVID-19 pandemic, telemedicine would be integrated into the care of oncology patients; however, sufficient evidence to guide this integration has not yet been established.…”

Section: Introductionmentioning

confidence: 99%

Effect of mHealth interventions on psychological issues experienced by women diagnosed with breast cancer receiving chemotherapy: A systematic review and meta-analysis

Akingbade

Nguyen

Chow

2022

Preprint

View full text Add to dashboard Cite

Background: A range of psychological issues often accompany breast cancer chemotherapy. Owing to their ubiquity, mobile phones have been used to deliver supportive interventions that address these issues. However, we currently lack sufficient evidence to guide the design of such interventions. Aim: To analyse and synthesise available evidence on the effectiveness of mobile-phone-based (mHealth) interventions in alleviating the psychological issues experienced by women receiving chemotherapy for breast cancer. Methods: A systematic literature search was conducted from 14 relevant databases. Revman 5.4 was used to pool the quantitative results from comparable studies for statistical meta-analysis. For clinically heterogeneous studies where statistical pooling of results was not possible, a narrative summary was used to present the findings. Results: The review included ten published studies which covered 1,548 patients. The meta-analysis results indicated a significant improvement in the quality of life (standardised mean difference [SMD] = 0.32, 95% confidence interval [CI] [0.07, 0.58], p = .01, I 2 = 17%). No significant effects were found for anxiety (SMD = -0.01, 95% CI [-0.26, 0.25], p = 0.96, I 2 = 53%) and depression (SMD = 0.02, 95% CI [-0.17, 0.20], p = .87, I 2 = 0%). Individual studies suggest reduced symptom prevalence ( p = .033, d =.27), symptom distress ( p = .004, d = .004), symptom interference ( p = .02, d = . 51),supportive care needs ( p < .05, d = 2.43); improved self-efficacy ( p = .03, d = 0.53), self-esteem ( p <.001, d = 0.87) andemotional functioning ( p = .008, d = .30). The methodological quality ranged from low to moderate. Conclusion: mHealth interventions might be helpful in addressing certain psychological issues experienced by this population, although the evidence is still being gathered and not yet conclusive. More rigorous trials are hereby warranted to confirm the suitable duration while addressing the methodological flaws found in previous studies

show abstract

“…Although it has been observed that mHealth will be integrated into the care of oncology patients in Nigeria during the COVID-19 pandemic [21], the evidence to guide this integration is lacking. Similarly, the need for culturally appropriate, research-tested mHealth interventions in this population has been documented [22].…”

Section: Introductionmentioning

confidence: 99%

Perception of mHealth Intervention for Psychoeducational Support Among Nigerian Women Receiving Chemotherapy for Breast Cancer: A Qualitative Study

Akingbade

Adediran

Somoye

et al. 2022

Preprint

View full text Add to dashboard Cite

Background Women diagnosed with BC receiving chemotherapy have reported various side effects, which adversely affect their psychological state. Evidence suggests that psychoeducational interventions (PEIs) delivered through mobile phones might effectively provide psychosocial support for this population. However, there is a lack of evidence on Nigerian women's perception of mHealth PEI, which prompted this study.MethodA multi-centre exploratory qualitative study was conducted among women with BC who had completed chemotherapy at two tertiary hospitals in Nigeria. Face-to-face focus group interviews were conducted at the oncology clinics. Data were collected using a semi-structured interview guide until data saturation was reached. Data were analysed using thematic analysis. Results Thirty-two women were recruited, with seven focus group interviews conducted. The participants were between 22 and 75 years old and mostly diagnosed with Stage III BC. Four main themes emerged from the data analysis, including experiences of BC diagnosis and treatment phase, patients’ needs during chemotherapy, coping with chemotherapy and perception of mHealth intervention for psychoeducational support. The participants found that mHealth intervention is acceptable, and the suggested contents include information on chemotherapy, how to deal with the fear of chemotherapy, nutritious diet locally available and information on exercise.Conclusion BC diagnosis was devastating, and psychological disturbances were experienced while receiving chemotherapy, but the participants perceived that mHealth intervention could provide psychological and informational support. This study will help design a culturally appropriate mHealth PEI for this population.

show abstract

Impact of mobile technologies on cervical cancer screening practices in Lagos, Nigeria (mHealth-Cervix): Protocol for a randomised controlled trial

Cited by 14 publications

References 12 publications

Impact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial

Impact of Mobile Technologies on Cervical Cancer Screening Practices in Lagos, Nigeria (mHealth-Cervix): A Randomized Controlled Trial

Effect of mHealth interventions on psychological issues experienced by women diagnosed with breast cancer receiving chemotherapy: A systematic review and meta-analysis

Perception of mHealth Intervention for Psychoeducational Support Among Nigerian Women Receiving Chemotherapy for Breast Cancer: A Qualitative Study

Contact Info

Product

Resources

About